Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population

被引:156
作者
Brink, PA
Crotti, L
Corfield, V
Goosen, A
Durrheim, G
Hedley, P
Heradien, M
Geldenhuys, G
Vanoli, E
Bacchini, S
Spazzolini, C
Lundquist, AL
Roden, DM
George, AL
Schwartz, PJ
机构
[1] IRCCS, Policlin San Matteo, Dept Cardiol, I-27100 Pavia, Italy
[2] Univ Stellenbosch, Dept Internal Med, ZA-7600 Stellenbosch, South Africa
[3] Univ Stellenbosch, US MRC, Ctr Cellular & Mol Biol, ZA-7600 Stellenbosch, South Africa
[4] Univ Stellenbosch, Bur Ind Math, ZA-7600 Stellenbosch, South Africa
[5] Univ Pavia, Dept Cardiol, I-27100 Pavia, Italy
[6] IRCCS, Policlin San Matteo, Pavia, Italy
[7] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA
[8] Vanderbilt Univ, Dept Med, Nashville, TN USA
关键词
arrhythmia; death; sudden; genetics; long-QT syndrome; nervous system; autonomic;
D O I
10.1161/CIRCULATIONAHA.105.572453
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-In the congenital long-QT syndrome (LQTS), there can be a marked phenotypic heterogeneity. Founder effects, by which many individuals share a mutation identical by descent, represent a powerful tool to further understand the underlying mechanisms and to predict the natural history of mutation-associated effects. We are investigating one such founder effect, originating in South Africa in approximately AD 1700 and segregating the same KCNQ1 mutation ( A341V). Methods and Results-The study population involved 320 subjects, 166 mutation carriers (MCs) and 154 noncarriers. When not taking beta-blocker therapy, MCs had a wide range of QTc values ( 406 to 676 ms), and 12% of individuals had a normal QTc ( <= 440 ms). A QTc > 500 ms was associated with increased risk for cardiac events ( OR = 4.22; 95% CI, 1.12 to 15.80; P = 0.033). We also found that MCs with a heart rate < 73 bpm were at significantly lower risk ( OR = 0.23; 95% CI, 0.06 to 0.86; P = 0.035). This study also unexpectedly determined that KCNQ1-A341V is associated with greater risk than that reported for large databases of LQT1 patients: A341V MCs are more symptomatic by age 40 years (79% versus 30%) and become symptomatic earlier ( 7 +/- 4 versus 13 +/- 9 years, both P < 0.001). Accordingly, functional studies of KCNQ1-A341V in CHO cells stably expressing IKs were conducted and identified a dominant negative effect of the mutation on wild-type channels. Conclusions-KCNQ1-A341V is a mutation associated with an unusually severe phenotype, most likely caused by the dominant negative effect of the mutation. The availability of an extended kindred with a common mutation allowed us to identify heart rate, an autonomic marker, as a novel risk factor.
引用
收藏
页码:2602 / 2610
页数:9
相关论文
共 40 条
[31]   Autonomic control of cardiac action potentials - Role of potassium channel kinetics in response to sympathetic stimulation [J].
Terrenoire, C ;
Clancy, CE ;
Cormier, JW ;
Sampson, KJ ;
Kass, RS .
CIRCULATION RESEARCH, 2005, 96 (05) :E25-E34
[32]   PROTECTIVE ZONE AND DETERMINATION OF VULNERABILITY TO VENTRICULAR-FIBRILLATION [J].
VERRIER, RL ;
BROOKS, WW ;
LOWN, B .
AMERICAN JOURNAL OF PHYSIOLOGY, 1978, 234 (05) :H592-H596
[33]  
Vincent GM, 2003, CIRCULATION, V108, P506
[34]   THE SPECTRUM OF SYMPTOMS AND QT INTERVALS IN CARRIERS OF THE GENE FOR THE LONG-QT SYNDROME [J].
VINCENT, GM ;
TIMOTHY, KW ;
LEPPERT, M ;
KEATING, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (12) :846-852
[35]   Functional effects of mutations in KvLQT1 that cause long QT syndrome [J].
Wang, Z ;
Tristani-Firouzi, M ;
Xu, Q ;
Lin, M ;
Keating, MT ;
Sanguinetti, MC .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1999, 10 (06) :817-826
[36]   Compound mutations - A common cause of severe long-QT syndrome [J].
Westenskow, P ;
Splawski, I ;
Timothy, KW ;
Keating, MT ;
Sanguinetti, MC .
CIRCULATION, 2004, 109 (15) :1834-1841
[37]   Pathophysiological mechanisms of dominant and recessive KVLQT1 K+ channel mutations found in inherited cardiac arrhythmias [J].
Wollnik, B ;
Schroeder, BC ;
Kubisch, C ;
Esperer, HD ;
Wieacker, P ;
Jentsch, TJ .
HUMAN MOLECULAR GENETICS, 1997, 6 (11) :1943-1949
[38]   Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome [J].
Zareba, W ;
Moss, AJ ;
Sheu, G ;
Kaufman, ES ;
Priori, S ;
Vincent, GM ;
Towbin, JA ;
Benhorin, J ;
Schwartz, PJ ;
Napolitano, C ;
Hall, WJ ;
Keating, MT ;
Qi, M ;
Robinson, JL ;
Andrews, ML .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2003, 14 (11) :1149-1153
[39]   Modulating effects of age and gender on the clinical course of long QT syndrome by genotype [J].
Zareba, W ;
Moss, AJ ;
Locati, EH ;
Lehmann, MH ;
Peterson, DR ;
Hall, J ;
Schwartz, PJ ;
Vincent, GM ;
Priori, SG ;
Benhorin, J ;
Towbin, JA ;
Robinson, JL ;
Andrews, ML ;
Napolitano, C ;
Timothy, K ;
Zhang, L ;
Medina, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) :103-109
[40]   Influence of the genotype on the clinical course of the long-QT syndrome [J].
Zareba, W ;
Moss, AJ ;
Schwartz, PJ ;
Vincent, GM ;
Robinson, JL ;
Priori, SG ;
Benhorin, J ;
Locati, EH ;
Towbin, JA ;
Keating, MT ;
Lehmann, MH ;
Hall, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (14) :960-965